Ryan Specialty Group stock hits 52-week low at 59.77 USD

Published 31/07/2025, 14:34
Ryan Specialty Group stock hits 52-week low at 59.77 USD

Ryan Specialty Group Holdings Inc’s stock has reached a new 52-week low, hitting 59.77 USD. The insurance services provider, with a market capitalization of $15.8 billion and impressive revenue growth of 22.5% over the last twelve months, has shown resilience despite market volatility with its relatively low beta of 0.65. This marks a significant point for the company’s stock as it navigates the current market conditions. Over the past year, the stock has experienced a decline of 3.76%, reflecting challenges that may have influenced investor sentiment. According to InvestingPro analysis, the stock appears undervalued at current levels, with analysts setting price targets as high as $90. The drop to this 52-week low underscores the volatility and pressures present in the market, as investors continue to assess the company’s performance and future prospects. For deeper insights and additional ProTips on Ryan Specialty Group, explore the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Ryan Specialty reported first-quarter earnings that aligned with expectations, posting an adjusted earnings per share of $0.39. The company’s revenue increased by 25% year-over-year to $690.2 million, surpassing the consensus forecast of $683.49 million. Despite this revenue growth, net income turned negative during the quarter. Additionally, Ryan Specialty completed the acquisition of J.M. Wilson Corporation, a Michigan-based insurance firm, integrating its operations into Ryan Specialty’s binding authority division. This acquisition was initially announced in June 2025 and is expected to enhance the company’s presence in the Midwest. In another development, Goldman Sachs upgraded Ryan Specialty’s stock rating from Neutral to Buy, raising the price target to $81.00. The upgrade is based on the firm’s potential for organic growth, revenue expansion, and margin improvement. Goldman Sachs also highlighted Ryan Specialty’s capability to outperform peers in growth and profitability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.